CXSE vs KURE
WisdomTree Trust WisdomTree China ex-State-Owned Enterprises Fund against KraneShares MSCI All China Health Care Index ETF: cost, size, returns, what they hold and how much of it is the same.
Overlap by weight
6%
20 shared positions
Fee gap
33 bp
CXSE is cheaper
1-year return gap
9.5 pts
KURE is ahead
Larger fund
CXSE
$450M
Side by side
| CXSE | KURE | |
|---|---|---|
| Fund | WisdomTree Trust WisdomTree China ex-State-Owned Enterprises Fund | KraneShares MSCI All China Health Care Index ETF |
| Issuer | WisdomTree | KraneShares |
| Category | Single Country | Single Country |
| Expense ratio | 0.32% | 0.65% |
| Assets | $450M | $110M |
| Average daily dollar volume | $949K | $1.5M |
| Listed | Sep 19, 2012 | Jan 31, 2018 |
| FrenzyCap score | 62 | 38 |
| 1-month return | −3.1% | +5.2% |
| 3-month return | −7.5% | +11.0% |
| Year to date | −12.9% | +9.9% |
| 1-year return | −22.1% | −12.6% |
| 30-day volatility | 17.3% | 29.4% |
| Worst drawdown, 1 year | −22.4% | −29.7% |
| Trailing 12-month yield | 1.99% | 3.82% |
| Holdings | 264 | 63 |
| Top 10 weight | 35.5% | 53.9% |
| Look-through P/E | — | — |
| Holdings vs fair value | — | — |
| Holdings above 200-day average | — | — |
| Net flow, latest 3 reported months | −$24M thru Jun 2026 | −$3.3M thru Jun 2026 |
| 30-day implied volatility | — | 51.2% |
| Holdings as of | as of Jun 30, 2026SEC filing | as of Jun 30, 2026SEC filing |
Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.
Largest shared holdings
6% of CXSE · 62% of KURE| Holding | CXSE | KURE |
|---|---|---|
| WUXI APPTEC CO LTD | 1.15% | 5.79% |
| JIANGSU HENGRUI PHARMACEUTICALS CO LTD | 0.83% | 4.59% |
| WUXI BIOLOGICS (CAYMAN) INC | 0.56% | 7.51% |
| INNOVENT BIOLOGICS INC | 0.51% | 8.80% |
| WUXI APPTEC CO LTD | 0.38% | 3.35% |
| AKESO INC | 0.32% | 3.72% |
| SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD | 0.31% | 4.28% |
| SINO BIOPHARMACEUTICAL LTD | 0.23% | 3.38% |
| HANSOH PHARMACEUTICAL GROUP CO LTD | 0.22% | 2.85% |
| 3SBIO INC | 0.19% | 2.49% |
| LEGN | 0.18% | 1.28% |
| SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO LTD | 0.15% | 1.85% |
| SHANGHAI UNITED IMAGING HEALTHCARE CO LTD | 0.15% | 2.27% |
| GENSCRIPT BIOTECH CORP | 0.14% | 1.11% |
| WUXI XDC CAYMAN INC | 0.12% | 1.35% |
| REMEGEN CO LTD | 0.12% | 1.05% |
| XTALPI HOLDINGS LTD | 0.11% | 1.00% |
| AIER EYE HOSPITAL GROUP CO LTD | 0.10% | 2.10% |
| SICHUAN KELUN PHARMACEUTICAL CO LTD | 0.10% | 1.61% |
| SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO LTD | 0.06% | 1.30% |
Sector mix of the stock holdings
| Sector | CXSE | KURE | Gap |
|---|---|---|---|
| Industrials | 1.8% | 0.0% | +1.8% |
| Health Care | 0.2% | 1.3% | −1.1% |
| Consumer Discretionary | 1.0% | 0.0% | +1.0% |
| Technology | 0.7% | 0.0% | +0.7% |
| Financials | 0.2% | 0.0% | +0.2% |
| Consumer Staples | 0.1% | 0.0% | +0.1% |
| Communication Services | 0.1% | 0.0% | +0.1% |
More: full overlap table · CXSE holdings · KURE holdings
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.